Annual Accounts Payable
$4.62 M
+$1.63 M+54.34%
December 31, 2023
Summary
- As of February 7, 2025, CHRO annual accounts payable is $4.62 million, with the most recent change of +$1.63 million (+54.34%) on December 31, 2023.
- CHRO annual accounts payable is now at all-time high.
Performance
CHRO Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$1.28 M
+$444.08 K+53.16%
September 30, 2024
Summary
- As of February 7, 2025, CHRO quarterly accounts payable is $1.28 million, with the most recent change of +$444.08 thousand (+53.16%) on September 30, 2024.
- Over the past year, CHRO quarterly accounts payable has dropped by -$3.34 million (-72.31%).
- CHRO quarterly accounts payable is now -72.31% below its all-time high of $4.62 million, reached on December 31, 2023.
Performance
CHRO Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
CHRO Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +54.3% | -72.3% |
| 3 y3 years | - | - |
| 5 y5 years | - | - |
CHRO Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +79.1% | -72.3% | +53.2% |
| 5 y | 5-year | at high | +79.1% | -72.3% | +53.2% |
| alltime | all time | at high | +79.1% | -72.3% | +53.2% |
Chromocell Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $1.28 M(+53.2%) |
| Jun 2024 | - | $835.41 K(-65.3%) |
| Mar 2024 | - | $2.41 M(-47.9%) |
| Dec 2023 | $4.62 M | $4.62 M(+11.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2023 | - | $4.16 M(+17.5%) |
| Jun 2023 | - | $3.54 M(+5.4%) |
| Mar 2023 | - | $3.36 M(+12.3%) |
| Dec 2022 | $2.99 M(+16.0%) | $2.99 M(+16.0%) |
| Dec 2021 | $2.58 M | $2.58 M |
FAQ
- What is Chromocell Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Chromocell Therapeutics?
- What is Chromocell Therapeutics annual accounts payable year-on-year change?
- What is Chromocell Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Chromocell Therapeutics?
- What is Chromocell Therapeutics quarterly accounts payable year-on-year change?
What is Chromocell Therapeutics annual accounts payable?
The current annual accounts payable of CHRO is $4.62 M
What is the all time high annual accounts payable for Chromocell Therapeutics?
Chromocell Therapeutics all-time high annual accounts payable is $4.62 M
What is Chromocell Therapeutics annual accounts payable year-on-year change?
Over the past year, CHRO annual accounts payable has changed by +$1.63 M (+54.34%)
What is Chromocell Therapeutics quarterly accounts payable?
The current quarterly accounts payable of CHRO is $1.28 M
What is the all time high quarterly accounts payable for Chromocell Therapeutics?
Chromocell Therapeutics all-time high quarterly accounts payable is $4.62 M
What is Chromocell Therapeutics quarterly accounts payable year-on-year change?
Over the past year, CHRO quarterly accounts payable has changed by -$3.34 M (-72.31%)